24% of Chronic Kidney Disease (CKD) patients also have Peripheral Arterial Disease (PAD)

Understanding the Link Between Chronic Kidney Disease (CKD) and Peripheral Arterial Disease (PAD)

Did you know that 24% of Chronic Kidney Disease (CKD) patients also suffer from Peripheral Arterial Disease (PAD)? This statistic highlights the critical intersection between these two serious health conditions. Both CKD and PAD share many of the same risk factors, making it essential for healthcare professionals to diagnose and monitor these conditions closely.

The Bidirectional Relationship Between CKD and PAD

Chronic Kidney Disease is not only one health problem; it's an independent risk factor for developing Peripheral Arterial Disease. In turn, cardiovascular diseases, including PAD, also significantly increase the risk of CKD. Among the common risk factors for these overlapping conditions are:
  • Hypertension
  • Diabetes
  • Smoking
  • Overweight/Obesity
The key to early detection of PAD, especially in patients at risk, like those with CKD, is crucial. The potential for developing PAD increases as kidney function declines, possibly leading to severe complications like amputations and cardiovascular events. Thus, the risk of arterial blockages will intensify with the CKD progression; hence, early diagnosis and timely intervention are important.

Early Detection and Diagnosis: Why Ankle-Brachial Index (ABI) Matters

The gold standard for diagnosing PAD is the Ankle-Brachial Index (ABI). This is a simple, non-invasive test that measures the ratio of blood pressure at the ankle to that at the arm. It is a very important diagnostic tool, especially in patients at high cardiovascular risk, including those with CKD.

ESC Guidelines 2017 recommended that patients at risk for atherosclerotic cardiovascular events should routinely have ABI measured. Similarly, KDOQI Guidelines support regular screening of ABI in patients with CKD, preferably those on dialysis. Regular surveillance of ABI not only aids in detecting arterial blockages but also prevents further development of PAD by improving management of both cardiovascular and kidney health. 

MESI ABI.png

Simplifying ABI Measurement with Advanced Technology

Traditional ABI measurement often involves the use of a manual Doppler probe, which can be time-consuming and complex. However, automated ABI measuring devices are revolutionizing the process. These devices provide quick, accurate, and user-friendly measurements, enabling healthcare professionals to diagnose PAD efficiently without compromising time spent managing CKD.

Clinical Insights: The Importance of ABI in Vascular Health

The importance of the ABI measurement for vascular diagnostics in patients with CKD was underlined by Prof. Dr. Bojan Knap, MD, a renowned expert in Internal Medicine. "Vascular diagnostics, especially non-invasive, can form the basis for better management of vascular diseases in patients with chronic renal disease and those receiving replacement therapy. The ABI test is an important tool in the follow-up of vascular conditions, guiding both lifestyle changes and pharmacological treatments".

The use of automated ABI devices finally allows the measurement of ABI in all dialysis patients without depriving other treatments of the critical time they need. This will finally permit a comprehensive vascular management, helping to lighten risks bound to CKD and PAD.

Learn More About MESI ABPI MD: A Revolutionary Tool for ABI Measurement

References

  1. Aboyans, V., et al. (2018). 2017 ESC Guidelines on the Diagnosis and Treatment of Peripheral Arterial Diseases. Revista Española de Cardiología (English Edition), 71(2), p.111.
  2. DeLoach, S., & Mohler, E. (2007). Peripheral Arterial Disease: A Guide for Nephrologists. Clinical Journal of the American Society of Nephrology, 2(4), pp.839-846.
  3. Garimella, P., & Hirsch, A. (2014). Peripheral Artery Disease and Chronic Kidney Disease: Clinical Synergy to Improve Outcomes. Advances in Chronic Kidney Disease, 21(6), pp.460-471.
  4. K/DOQI Clinical Practice Guidelines for Cardiovascular Disease in Dialysis Patients. (2005). American Journal of Kidney Diseases, 45, pp.16-153.